Kirkstall, an innovative Sheffield company, has launched a video in support of their bid to win a prestigious Technology Strategy Board prize. Their technology enables different human cell types to be grown in an interconnected way, using a microfluidic flow system. This ‘quasi vivo’ system more accurately reflects the way in which cells grow in the body, and hence provides more relevant results. We are delighted that Managing Director Dr Malcolm Wilkinson praised our campaign for safer medicines during the course of his video, and wish Kirkstall the best of luck! Winning the £100k prize would enable Kirkstall to develop their technology even further. Please view and rate their entry here (or here). Please note: as only scientific comments are requested, it is perfectly acceptable to vote without commenting!
World Patient Safety Day is grounded in the most fundamental principle of medicine – first do no harm “Medication Safety” is the theme for World Patient Safety Day 2022. Safer Medicines Trust is a patient safety charity whose mission is to improve the safety of medicines, so we very much support calls for “Medication Without Harm”. The World […]The crisis of Alzheimer’s disease research: it’s time to embrace a new approach to help patients
The problem Alzheimer’s disease (AD) is a leading cause of death in the UK and along with other dementias, is responsible for almost 11% of all deaths in England.1 More than 209,000 new cases are diagnosed each year across the UK.2 It remains a leading cause of death and disability worldwide3, affecting nearly 50 million […]